Article
OCTN1 Is a High-Affinity Carrier of Nucleoside Analogues
16 Feb 2017
Abstract excerpt
Abstract Resistance to xenobiotic nucleosides used to treat acute myeloid leukemia (AML) and other cancers remains a major obstacle to clinical management. One process suggested to participate in resistance is reduced uptake into tumor cells via nucleoside transporters, although precise mechanisms are not understood. Through transcriptomic profiling, we determined that low expression of the ergothioneine...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
